These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9248766)

  • 41. Toxicological studies in a Distalgesic addict.
    Roberts I; Flanagan RJ; Strang J; Prescott LF
    Hum Toxicol; 1986 May; 5(3):207-10. PubMed ID: 3710498
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High prevalence of small LDL particles in non-insulin-dependent diabetic patients with nephropathy.
    Hirano T; Naito H; Kurokawa M; Ebara T; Nagano S; Adachi M; Yoshino G
    Atherosclerosis; 1996 Jun; 123(1-2):57-72. PubMed ID: 8782837
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cisapride raises the bioavailability of paracetamol by inhibiting its glucuronidation in man.
    Itoh H; Nagano T; Takeyama M
    J Pharm Pharmacol; 2001 Jul; 53(7):1041-5. PubMed ID: 11480539
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Paracetamol metabolism after general anaesthesia.
    Lewis RP; Dunphy JA; Reilly CS
    Eur J Anaesthesiol; 1991 Nov; 8(6):445-50. PubMed ID: 1765042
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elevated serum and urinary thrombomodulin levels in patients with non-insulin-dependent diabetes mellitus.
    Shimano H; Takahashi K; Kawakami M; Gotoda T; Harada K; Shimada M; Yazaki Y; Yamada N
    Clin Chim Acta; 1994 Mar; 225(2):89-96. PubMed ID: 8088010
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The dependence of paracetamol absorption on the rate of gastric emptying.
    Heading RC; Nimmo J; Prescott LF; Tothill P
    Br J Pharmacol; 1973 Feb; 47(2):415-21. PubMed ID: 4722050
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effects of electroacupuncture at "Zusanli" (ST 36) on Pharmacokinetics of paracetamol in rates].
    Yan M; Wang LP; Meng GY; Chen SH; Yang B
    Zhongguo Zhen Jiu; 2010 Jul; 30(7):577-82. PubMed ID: 20862943
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative pharmacokinetics of Panadol Extend and immediate-release paracetamol in a simulated overdose model.
    Tan C; Graudins A
    Emerg Med Australas; 2006 Aug; 18(4):398-403. PubMed ID: 16842311
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanism of increased serum cytokeratin 19 fragment levels in patients with diabetic nephropathy as a model of chronic renal failure.
    Kashiwabara K; Kishi K; Nakamura H; Yagyu H; Kobayashi K; Watanabe O; Matsuoka T
    Intern Med; 1998 Nov; 37(11):917-21. PubMed ID: 9868951
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Investigating paracetamol pharmacokinetics using venous and capillary blood and saliva sampling.
    Rittau AM; McLachlan AJ
    J Pharm Pharmacol; 2012 May; 64(5):705-11. PubMed ID: 22471366
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of insulin on urinary phosphate excretion in type II diabetes mellitus with or without renal insufficiency.
    Ishimura E; Nishizawa Y; Emoto M; Maekawa K; Morii H
    Metabolism; 1996 Jun; 45(6):782-6. PubMed ID: 8637455
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Paracetamol and its metabolites in saliva and plasma in chronic dialysis patients.
    Lee HS; Ti TY; Lye WC; Khoo YM; Tan CC
    Br J Clin Pharmacol; 1996 Jan; 41(1):41-7. PubMed ID: 8824692
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
    Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The pharmacokinetics of pioglitazone in patients with impaired renal function.
    Budde K; Neumayer HH; Fritsche L; Sulowicz W; Stompôr T; Eckland D
    Br J Clin Pharmacol; 2003 Apr; 55(4):368-74. PubMed ID: 12680885
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of plasma and urinary endothelin-1 in early diabetic and hypertensive nephropathy.
    De Mattia G; Cassone-Faldetta M; Bellini C; Bravi MC; Laurenti O; Baldoncini R; Santucci A; Ferri C
    Am J Hypertens; 1998 Aug; 11(8 Pt 1):983-8. PubMed ID: 9715792
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Duration of action and pharmacokinetics of the oral antidiabetic drug gliquidone in patients with non-insulin-dependent (type 2) diabetes mellitus.
    von Nicolai H; Brickl R; Eschey H; Greischel A; Heinzel G; König E; Limmer J; Rupprecht E
    Arzneimittelforschung; 1997 Mar; 47(3):247-52. PubMed ID: 9105542
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Insulin receptor substrate-1 and glucose transporter gene polymorphisms in noninsulin-dependent diabetes mellitus].
    Liu Z; Guan T; Chen Z
    Zhonghua Yi Xue Za Zhi; 1998 Sep; 78(9):662-5. PubMed ID: 11038788
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High prevalence of small dense LDL in diabetic nephropathy is not directly associated with kidney damage: a possible role of postprandial lipemia.
    Hirano T; Oi K; Sakai S; Kashiwazaki K; Adachi M; Yoshino G
    Atherosclerosis; 1998 Nov; 141(1):77-85. PubMed ID: 9863540
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Study of paracetamol 1-g oral solution bioavailability.
    Farre M; Roset PN; Abanades S; Menoyo E; Alvarez Y; Rovira M; Baena A
    Methods Find Exp Clin Pharmacol; 2008; 30(1):37-41. PubMed ID: 18389096
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics of gentamicin in patients with various levels of diabetic proteinuria.
    White JR; Freerksen A; Gould B; Sclar DA
    Clin Ther; 1994; 16(2):173-80. PubMed ID: 8062313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.